Categoría: Stem Cell Research
-
Panamanian-US Scientific Research Supports Using Fat Stem Cells to Treat Rheumatoid Arthritis
Dallas, TX (PRWEB) February 21, 2012 A Panamanian-led, multidisciplinary research team has published the first description of non-expanded fat stem cells in the treatment of rheumatoid arthritis patients. «Autologous Stromal Vascular Fraction Therapy for Rheumatoid Arthritis: Rationale and Clinical Safety,» which appears in the January publication of the International Archives of Medicine, followed 13 rheumatoid…
-
Stem Cells in Theory and Practice
Dr. Douglas J. Herthel of Alamo Pintado Equine Medical Center in Los Olivos, California was one of the first practitioners to use stem cells, beginning in 1995. Herthel used stem cells from bone marrow to treat ligament and tendon injuries in horses. The results from these treatments were so promising that he began using stem…
-
Rare Heart Defect Reproduced in Petri Dish, Hope for Cure
Dr. Ananya Mandal, MD A team of researchers has created beating heart cells in the lab using skin cells of children with a rare heart defect. The team, led by Ricardo Dolmetsch of Stanford University took skin cells from children with Timothy syndrome, a rare heart condition commonly associated with autism, as well as syndactyly…
-
First Scientist to identify stem cells dies at 84
Thomas Maugh II, Washington Post Ernest Armstrong McCulloch, 84, passed away January 20 in his hometown of Toronto. Dr. McCulloch, a medical doctor who attended the University of Toronto is best remembered as the first, along with biophysicist James E. Till, to isolate and identify a stem cell. Their discovery was reached while both were…
-
Therapeutic Effects of Intra-Arterial Delivery of Bone Marrow Stromal Cells in Traumatic Brain Injury of Rats—In Vivo Cell Tracking Study by Near-Infrared Fluorescence Imaging
Neurosurgery: February 2012 – Volume 70 – Issue 2 – p 435–444 doi: 10.1227/NEU.0b013e318230a795 Research-Animal Osanai, Toshiya MD, PhD*; Kuroda, Satoshi MD, PhD*; Sugiyama, Taku MD, PhD*; Kawabori, Masahito MD*; Ito, Masaki MD*; Shichinohe, Hideo MD, PhD*; Kuge, Yuji PhD‡; Houkin, Kiyohiro MD, PhD*; Tamaki, Nagara MD, PhD‡; Iwasaki, Yoshinobu MD, PhD* Abstract BACKGROUND: A…
-
Inhaling Stem Cells for Treating Parkinson’s
Danielyan et al. Rejuvenation Res. Stem cells have been delivered in a variety of ways: intravenously, into the spinal canal (intrathecally), into the brain (stereotactically), into the joint (intra-articularly), and into the cardiac muscle (endocardially). Scientists from the Department of Clinical Pharmacology, University Hospital of Tübingen , Tübingen, Germany have reported today a new way…
-
Ischemic Stroke Recovery May Be Improved Using Stem Cell Therapy
At the American Heart Association’s International Stroke Conference in New Orleans, two studies suggested that stem cell therapy improves functional recovery following subacute ischemic stroke and may aid in regenerative therapy. One hundred and twenty subacute ischemic stroke patients were treated with mononuclear bone marrow-derived stem cells. Patients ranged in age from eighteen to seventy…
-
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, Du MQ, Luan SL, Altmann DR, Thompson AJ, Compston A, Scott MA, Miller DH, Chandran S. Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. Abstract BACKGROUND: More than half of patients with multiple sclerosis have progressive disease characterised by accumulating disability. The…
-
Fat Stem Cells Turn to Muscle: A Treatment for Muscular Dystrophy?
New research published in the journal Biomaterials by University of California, San Diego researcher Adam Engler suggests fat-derived stem cells that are developed on a stiff surface transform into mature muscle cells. This remarkable discovery could lead to new treatments for muscular dystrophy in the future. Fat stem cells and bone marrow stem cells were…
-
Medistem Begins Phase II Clinical Trial for Heart Failure
Medistem Inc announced today treatment of 3 heart failure patients in the Non-Revascularizable IschEmic Cardiomyopathy treated with Retrograde COronary Sinus Venous DElivery of Cell TheRapy (RECOVER-ERC) trial. The trial is aimed at assessing safety and efficacy of the company’s Endometrial Regenerative Cell (ERC) stem cell product in 60 heart failure patients who have no available…